New funds try to defer tax payments but don't yet have a proven record. ...

Core Viewpoint - Boeing is anticipated to regain some authority from regulators to conduct final safety checks on jets [1] Group 1 - The company is expected to enhance its operational capabilities by performing final safety checks, which may lead to improved efficiency in the production process [1]

Group 1 - U.S. stock futures showed volatility following President Trump's announcement of new tariffs on drugs, trucks, and furniture [1] - The market reaction to the tariff news was relatively calm, indicating resilience among investors [1]

Group 1 - The real-estate listings company is focusing on increasing revenue while managing head count growth to achieve profitability goals [1]

Big pharma stocks rose slightly in U.S. premarket trading, small and midsize companies in Europe were hit, and Asian pharma stocks fell across the board, leading the markets lower. ...

Core Viewpoint - Meta is focusing on the future of artificial intelligence, aiming to extend user experiences beyond traditional devices like smartphones and personal computers [1] Group 1 - The company is investing in AI technologies that could redefine user interaction and engagement [1] - Meta's strategy includes developing new platforms and applications that leverage AI capabilities [1] - The emphasis is on creating immersive experiences that integrate AI into daily life [1]

Core Viewpoint - President Trump announced plans to impose new tariffs on pharmaceuticals and large trucks, aiming to protect American jobs and industries [1] Group 1: Pharmaceuticals - The proposed tariffs are part of a broader strategy to reduce dependency on foreign-made drugs and encourage domestic production [1] - The pharmaceutical industry is expected to face increased costs, which may lead to higher prices for consumers [1] Group 2: Trucking Industry - New levies on big trucks are intended to support American manufacturers and address trade imbalances [1] - The trucking industry may experience disruptions as companies adjust to the new tariffs, potentially impacting supply chains [1]

Core Viewpoint - The announcement of new tariffs by Trump, including a 100% levy on drugs from companies not building plants in the U.S., has led to a decline in the value of the dollar [1] Group 1 - The new tariffs specifically target pharmaceutical companies that do not invest in U.S. manufacturing [1] - The 100% levy on drugs is a significant increase that could impact pricing and availability in the market [1] - The announcement has immediate effects on currency valuation, as evidenced by the dollar turning lower [1]

Core Viewpoint - The court is set to determine if President Trump has the authority to remove Lisa Cook from the Federal Reserve's board, which is perceived by former officials as a potential threat to the independence of the central bank [1] Group 1 - The decision regarding Lisa Cook's position on the Federal Reserve's board is significant for the future governance of the central bank [1] - Former officials express concerns that such a removal could undermine the autonomy of the Federal Reserve [1]

Core Viewpoint - Tariffs on drugs will be imposed on companies that do not have manufacturing plants in the U.S. [1] Group 1 - The new tariffs aim to incentivize pharmaceutical companies to establish production facilities within the United States [1] - Companies without U.S. plants will face increased costs, potentially affecting their pricing strategies and market competitiveness [1] - This policy is part of a broader initiative to boost domestic manufacturing and reduce reliance on foreign production [1]